Wild-type puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques

Journal of Virology

Volumn 76, Issue 1, 2002, Pages 444-449

  Klingstrom J ^a   Plyusnin, A ^a   Vaheri, A ^a   Lundkvist, A ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYTOKINE; NITRIC OXIDE; VACCINE; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RELEASE; HANTAVIRUS; IMMUNE RESPONSE; MACACA; NONHUMAN; PRIORITY JOURNAL; PUUMALA VIRUS; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION; VIRUS PATHOGENESIS;

ANIMALS; C-REACTIVE PROTEIN; CREATININE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HANTAVIRUS; HANTAVIRUS INFECTIONS; MACACA FASCICULARIS; NITRIC OXIDE;

EID: 0036133212     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.1.444-449.2002     Document Type: Article

References (41)

1. Vascular hyperpermeability induced by tumor necrosis factor and its augmentation by IL-1 and IFN-γ is inhibited by selective depletion of neutrophils with a monoclonal antibody
2. Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden
3. Direct genetic detection of Dobrava virus in Greek and Albanian patients with haemorrhagic fever with renal syndrome
4. Cell-mediated immunity to virus causing haemorrhagic fever with renal syndrome: Generation of cytotoxic T lymphocytes
5. Nephropathia epidemica: Detection of antigen in bank voles and serologic diagnosis of human infection
6. Epidemiological study of nephropathia epidemica in Finland 1989-1996
7. Diagnostic potential of Puumala virus nucleocapsid protein expressed in Drosophila melanogaster cells
8. T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: Identification of T-helper epitopes in a mouse model
9. A macaque model for hantavirus infection
10. Monkeys in hantavirus research
11. Increased production of nitric oxide in patients infected with the European variant of hantavirus
12. Antibodies to Puumala virus in humans determined by neutralization test
13. Pathogenesis of Puumala and other hantavirus infections
14. High-producer allele of tumour necrosis factor-alpha is part of the susceptibility MHC haplotype in severe Puumala virus-induced nephropathia epidemica
15. Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles
16. Annals of clinical research
17. Isolation of the etiologic agent of Korean hemorrhagic fever
18. Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome-relation to arterial hypotension and tumor necrosis factor
19. Elevated levels of tumor necrosis factor (TNF)-α, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome
20. Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: Definition of epitopes specific for acute immunoglobulin G recognition in humans
21. Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment
22. Characterization of Puumala virus nucleocapsid protein: Identification of B-cell epitopes and domains involved in protective immunity
23. The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays
24. Clinical picture of nephropathia epidemica in children
25. Hantavirus pulmonary syndrome and newly described hantaviruses in the United States
26. Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus
27. Puumala hantavirus genome in patients with nephropathia epidemica: Correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents
28. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants
29. Recombinant DNA vaccines for hantaviruses
30. Hantaviruses: A global disease problem
31. Hantaviruses
32. Pathogenic and clinical aspects of the renal involvement in hemorrhagic fever with renal syndrome
33. Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: A review
34. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacological study
35. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: An immunohistochemical study
36. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees
37. Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response
38. Interleukin 1 potentiates the lethal effect of tumor necrosis factor α/cachectin in mice
39. Experimental hantavirus infection in nonhuman primates
40. Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins